Children’s Hospital Colorado is pleased to announce that Thomas H. Inge, MD, PhD, has been selected as division head and professor of pediatric surgery, as well as the director of the hospital’s planned Adolescent Metabolic and Bariatric Surgery Program.
Before joining Children’s Colorado, Dr. Inge served as professor of surgery and pediatrics at the University of Cincinnati and Cincinnati Children’s Hospital Medical Center, where he practiced pediatric surgery with a focus on minimally invasive procedures for over 16 years. He received his MD and PhD degrees from the Medical College of Virginia, completed general surgical residency at Stanford University, and specialized in pediatric minimally invasive surgery during his fellowship at Children’s Hospital of Alabama.
Dr. Inge brings a wealth of experience in surgical outcomes research, having been awarded $15 million in research funding from the National Institutes of Health over the past decade, and having published more than 100 peer-reviewed manuscripts. He will continue to lead the multicenter Teen-Longitudinal Assessment of Bariatric Surgery (Teen-LABS) consortium, the largest and longest term prospective study of surgical treatment of adolescent obesity. In this role, he and a multi-institutional team of researchers working with him have greatly advanced the field through publications in the New England Journal of Medicine, Pediatrics, Diabetes Care, JAMA Pediatrics, Lancet Diabetes and Endocrinology, and others. In Denver, Dr. Inge will build on this work, and further expand clinical outcomes research, collaborating with investigators both in and outside of surgery.
Research and innovation are top priorities for Dr. Inge and are a major component of his vision for the future of pediatric surgery at Children’s Colorado. “Through research we are able to greatly amplify our impact on the lives of children,” Dr. Inge says. “It is not enough just to define outcomes and set best practices — we also need to be a resource for providers across the country, ensuring treatments and innovations are available to patients everywhere.”